[1]
|
李元青, 马成杰, 刘朝阳, 陈信义. 茶多酚联合反应停对人肺腺癌A549抑制作用研究[J]. 现代生物医学进展, 2007, 7(9): 1281-1283.
|
[2]
|
马成杰, 李元青, 刘朝阳, 陈信义, 孙颖立. 茶多酚联合重组人血管内皮抑制素(恩度)对人肺腺癌A549抑制作用研究[J]. 中国中医药信息杂志, 2008, 15(1): 41-43.
|
[3]
|
Moses, M.A., Wiederschain, D., Wu, I., et al. (1999) Troponin I Is Present in Human Cartilage and Inhibits Angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 96, 2645-2650.
https://doi.org/10.1073/pnas.96.6.2645
|
[4]
|
李渝萍, 陈敏, 陈彬, 等. 快速骨骼肌型肌钙蛋白I的研究进展[J]. 生命的化学, 2004, 24(3): 183-186.
|
[5]
|
Liu, X., Zhou, H. and Deng, X. (2007) Effect of Recombinant Human Troponin C on the Growth of Human Umbilicai Vein Endotheiiai Cells and Mouse Xenograft Tumor. Journal of Clinical Rehabilitative Tissue Engineering Research, 11, 7282-7285.
|
[6]
|
Feldman, L. and Rouleau, C. (2002) Troponin I Inhibits Capillary Endothelial Cell Proliferation by Interaction with the Cell’s bFGF Receptor. Microvascular Research, 63, 41-49.
|
[7]
|
Schmidt, K., Hoffend, J., Altmann, A., et al. (2006) Troponin I Overexpression Inhibits Tumor Growth, Perfusion, and Vascularization of Morris Hepatoma. The Journal of Nuclear Medicine, 47, 1506-1516.
|
[8]
|
Xie, Q., Yao, S., Chen, X., et al. (2012) A Polypeptide from Shark Troponin I Can Inhibit Angiogenesis and Tumor Growth. Molecular Biology Reports, 39, 1493-1501. https://doi.org/10.1007/s11033-011-0887-y
|
[9]
|
Presta, M., Dell’Era, P., Mitola, S., et al. (2005) Fibroblast Growth Factor/Fibroblast Growth Factor Receptor System in Angiogenesis. Cytokine & Growth Factor Reviews, 16, 159-178. https://doi.org/10.1016/j.cytogfr.2005.01.004
|
[10]
|
Pai, R., Szabo, I.L., Kawanaka, H., et al. (2000) Indomethacin Inhibits Endothelial Cell Proliferation by Suppressing Cell Cycle Proteins and PRB Phosphorylation: A Key to Its Antiangiogenic Action? Molecular Cell Biology Research Communications, 4, 111-116.
|
[11]
|
Dutour, A., Rabinovich-Chable, H., Kaletta, C., et al. (2004) Is Troponin I Gene Therapy Effective for Osteosarcoma Treatment? Study on a Human-Like Orthotopic Rat Model. Anticancer Research, 24, 3977-3972.
|
[12]
|
Barbara Fingleton (2008) MMPs as Therapeutic Targets—Still a Viable Option? Seminars in Cell & Developmental Biology, 19, 61-68.
|
[13]
|
Li, Q., Shen, P.Y., Wu, G., et al. (2003) Polycystin-2 Interacts with Troponin I, an Angiogenesis Inhibitor. Biochemistry, 42, 450-457. https://doi.org/10.1021/bi0267792
|
[14]
|
Fukumoto, S., Sakaguchi, T., You, M., et al. (2006) Tick Troponin I-Like Molecule Is a Potent Inhibitor for Angiogenesis. Microvascular Research, 71, 218-221.
|
[15]
|
Ara, M.N., Hyodo, M., Ohga, N., et al. (2014) Identification and Expression of Troponin T, a New Marker on the Surface of Cultured Tumor Endothelial Cells by Aptamer Ligand. Cancer Medicine, 3, 825-834.
https://doi.org/10.1002/cam4.260
|
[16]
|
Chen, C., Liu, J.-B., Bian, Z.-P., et al. (2014) Cardiac Troponin I Is Abnormally Expressed in Non-Small Cell Lung Cancer Tissues and Human Cancer Cells. International Journal of Clinical and Experimental Pathology, 7, 1314-1324.
|